Approved as an anxiolytic in Russia; marketed elsewhere as a calming, “non-addictive” alternative to benzodiazepines. Here’s what the evidence supports, why it’s not a substitute for treating anxiety, and the psychiatric-medication caution.
The one-sentence version: Selank is a real anti-anxiety medicine in Russia with a plausible GABA/serotonin mechanism and a gentler reputation than benzodiazepines, used elsewhere as a gray-market anxiolytic on thin Western evidence — and the non-negotiable point is that it should not be used to self-treat anxiety or to replace/taper prescribed psychiatric medication on your own.
Selank is a synthetic peptide based on tuftsin, a naturally occurring immune-system fragment, modified for stability. In Russia it is an approved medicine for generalized anxiety, typically given as a nasal spray. Outside Russia it has no such approval and is used off-label/gray-market as an anxiolytic nootropic — valued for a calming effect that, unlike benzodiazepines, is marketed as non-sedating and non-habit-forming.
Selank is thought to influence GABA and serotonin signaling, modulate BDNF, and affect immune pathways (a nod to its tuftsin origin). The GABA/serotonin activity is the proposed basis for its calming effect — and, because those are the systems many anxiety and depression medications act on, it’s also the basis for the interaction caution below.
In Russia, Selank has clinical use and supporting studies for anxiety. That history is real and is the strongest part of the evidence base.
Limited (elsewhere) — thin independent Western data; long-term safety unclearAs with Semax, most evidence is Russian and of variable accessibility/quality, with limited independent Western RCT data and limited long-term safety information. The “non-addictive” framing has some support but shouldn’t be over-read — it’s marketed that way more confidently than the long-term human data can yet prove.
Selank should not be used to self-treat an anxiety disorder, and not used to replace or taper prescribed anxiety or antidepressant medication on your own. It acts on GABA and serotonin systems that overlap with psychiatric drugs, so combining or substituting is an uncharacterized change that belongs with a prescriber. Anxiety that’s affecting your life is a medical issue deserving real care — not a gray-market peptide experiment. See our peptide & psychiatric-medication interactions guide.
Selank is one of the more appealing nootropic peptides because anxiety is so common and the “calm without dependence” pitch is attractive — and it is a real medicine in Russia. But the Western evidence is thin, the long-term safety and dependence claims aren’t fully proven, and it is emphatically not a do-it-yourself replacement for proper anxiety treatment. If anxiety is the real issue, that’s a conversation with a clinician first; if you still explore Selank, do it with realistic expectations, a tested product, and your prescriber informed.
An approved anti-anxiety medicine in Russia; used off-label/gray-market elsewhere as a calming nootropic for anxiety, stress, and focus. Real clinical use there; thin evidence for self-directed use elsewhere.
It’s thought to act on GABA and serotonin, modulate BDNF, and affect immune pathways — which is also why it interacts with psychiatric-medication systems.
Marketed as non-sedating and non-addictive, with some support for a gentler profile, but long-term human safety/dependence data is limited. Not a benzo, but not a proven substitute either.
No. Don’t self-treat anxiety or taper/replace prescribed meds with it. It overlaps with the systems those drugs target — a prescriber decision.
Not FDA-approved (approved in Russia); sold “research use only.” It was not part of the April 2026 Category 2 removal or the July 2026 PCAC list.
This guide is general legal and educational information, not legal or medical advice, and does not create an attorney-client or physician-patient relationship. It is written by a California-licensed attorney, not a physician. Selank is not FDA-approved; it affects neurotransmitter systems and must not be combined with psychiatric medications, or used to alter or taper them, without a licensed prescriber, and is not a substitute for professional anxiety care. Research peptides sold “for research use only” are not approved for human use. Verify current information before relying on it. Current as of June 20, 2026.